|

5 mg BGM0504 injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.1

Indications

  • Diabetes1
  • Overweight or Obesity1

Other1 trial

A Study of BGM0504 Injection in Participants with Obesity or Overweight
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.